Free · No account required · Powered by AI across the world's largest grants + funders database
Currently focused on US federal, state, and foundation grants.
Establishing a Center for the Advancement of SUD Pharmacotherapeutics (U54) is sponsored by National Institutes of Health (NIDA). Planning NOFO to establish a translational center for SUD pharmacotherapeutic development, training, and outreach.
Official opportunity description and requirements excerpt:
Opportunity Listing - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) An official website of the United States government Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. You've been logged out. Please sign in again. Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed): RFA-DA-26-058 Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) Agency: National Institutes of Health Assistance Listings: 93.279 -- Drug Use and Addiction Research Programs Last Updated: December 22, 2025 View version history on Grants.gov The National Institute on Drug Abuse (NIDA) seeks to advance its mission by establishing a Center that educates and supports researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics. The Center will also help advance the best concepts through initial experiments via technical and financial support. Previous NIDA-supported initiatives in early translational research have shown that drug addiction researchers are eager to acquire formal product development skills and access technical expertise and support. Prospective applicants are encouraged to: develop plans for a product development curriculum to be taught to SUD researchers, outline outreach and networking initiatives to engage the research community and recruit researchers' concepts for development within the Center, and describe the infrastructure support that may be provided for initial experiments. style="margin-left:0px;">Applications are not being solicited at this time. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. Investigators with expertise in the areas of drug discovery and development and institutional capacities to support such a Center are encouraged to begin to consider applying for this NOFO.Grant authorities that allow NIH to forecast this opportunity are as follows Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75 and 2 CFR Part 200]. Public and Indian housing authorities City or township governments Special district governments Federally recognized Native American tribal governments For-profit organizations other than small businesses Other Native American tribal organizations Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3)
Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) An official website of the United States government Official websites use . gov A . gov website belongs to an official government organization in the United States.
Secure . gov websites use HTTPS A lock ( ) or https:// means you’ve safely connected to the . gov website.
Share sensitive information only on official, secure websites. You've been logged out. Please sign in again.
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed): RFA-DA-26-058 Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) Agency: National Institutes of Health Assistance Listings: 93.
279 -- Drug Use and Addiction Research Programs Last Updated: December 22, 2025 View version history on Grants. gov The National Institute on Drug Abuse (NIDA) seeks to advance its mission by establishing a Center that educates and supports researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics.
The Center will also help advance the best concepts through initial experiments via technical and financial support. Previous NIDA-supported initiatives in early translational research have shown that drug addiction researchers are eager to acquire formal product development skills and access technical expertise and support.
Prospective applicants are encouraged to: develop plans for a product development curriculum to be taught to SUD researchers, outline outreach and networking initiatives to engage the research community and recruit researchers' concepts for development within the Center, and describe the infrastructure support that may be provided for initial experiments. style="margin-left:0px;">Applications are not being solicited at this time.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. Investigators with expertise in the areas of drug discovery and development and institutional capacities to support such a Center are encouraged to begin to consider applying for this NOFO.
Based on current listing details, eligibility includes: Governments, nonprofits, educational institutions, tribal organizations. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Approximately $3,000,000 for first year, one award Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is March 10, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Rural Communities Opioid Response Program (RCORP) - Impact is sponsored by Health Resources and Services Administration (HRSA). Funds community capacity building for prevention, treatment, and recovery services for substance use disorders in rural areas. Application snapshot: target deadline February 23, 2026; published funding information $200,000 - $1,000,000; eligibility guidance Rural organizations and communities addressing opioid response Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Bloomberg Initiative to Reduce Tobacco Use Grants Program is sponsored by Bloomberg Family Foundation Inc.. This program supports projects to develop and deliver high-impact, evidence-based tobacco control interventions in low- and middle-income countries. Funding focuses on policy reforms such as strengthening tobacco taxation, implementing smoke-free laws, advertising bans, and graphic pack warnings. It includes both 'Open Rounds' for broad policy work and a specific 'Tobacco Industry Interference' (TII) subset to counter industry tactics. Geographic focus: Low- and middle-income countries (Global) Focus areas: Public Health, Tobacco Control, Policy Reform Official opportunity description and requirements excerpt: Contact | Bloomberg Philanthropies Strengthening Local Arts Organizations Connecting Audiences to Culture Online or Onsite Advancing the Arts Around the World Collaborating with Cultural Funders Expanding College Access and Success Supporting Career and Technical Education Supporting Educational Institutions Supporting Sustainable Cities Driving Sustainable Finance Spurring Innovation in Cities Strengthening City Data to Improve Lives Promoting Healthy Food Choices Combating the Overdose Epidemic Increasing Access to Reproductive Health Care Promoting Cardiovascular Health Building Public Health Coalitions Strengthening Health Data Women’s Economic Development Perelman Performing Arts Center at the World Trade Center Charlotte and William Bloomberg Medford Public Library Goldman Sachs 10,000 Small Businesses English French German Spanish Portuguese (Brazil) Italian Korean Russian Hindi Japanese Chinese (Simplified) Chinese (Traditional) English French German Spanish Portuguese (Brazil) Italian Korean Russian Hindi Japanese Chinese (Simplified) Chinese (Traditional) Bloomberg Philanthropies is only as strong as its connections. Whether you have questions or want to get involved, we want to hear from you. Please use the following information or fill out the form below to contact us and we’ll do our best to send you a prompt response. If your inquiry involves a request for funding or partnership, please note Bloomberg Philanthropies works with existing partners on all of our key initiatives and does not make grants outside our focus areas or directly to individuals. Grant proposals are by invitation only and news on grants competitions are posted regularly on our website. Members of the media may contact communications@bloomberg.org . Choose Your Subject General Inquiries Grants Events Careers Arts Education Environment Government Innovation Public Health Bloomberg Associates Founder's Projects Please note grant proposals are by invitation only and we do not make grants outside our focus areas or directly to individuals. Top photo: Christo’s temporary sculpture in Hyde Park, London, “The London Mastaba,” located in Serpentine Lake, Hyde Park during summer of 2018. Application snapshot: target deadline February 25, 2026; published funding information $50,000 - $250,000 per year; eligibility guidance Government agencies and non-governmental organizations (NGOs) in low- and middle-income countries (LMICs) as categorized by the World Bank. Priority is given to countries with the highest tobacco use. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Application snapshot: target deadline March 10, 2026; published funding information Approximately $3,000,000 for first year, one award; eligibility guidance Governments, nonprofits, educational institutions, tribal organizations.
Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Grant authorities that allow NIH to forecast this opportunity are as follows Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75 and 2 CFR Part 200].
Public and Indian housing authorities City or township governments Special district governments Federally recognized Native American tribal governments For-profit organizations other than small businesses Other Native American tribal organizations Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3) Private institutions of higher education Independent school districts Public and state institutions of higher education Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.
S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U. S.)
Entities (Foreign Institutions). Grantor contact information No documents are currently available. Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : To give feedback, contact: simpler@grants.
gov Grants. gov Support Center For technical support, contact: support@grants. gov Grants.
gov Program Management Office Grantors, contact the PMO through your Agency Point of Contact . An official website of the U. S.
Department of Health and Human Services Office of the Inspector General Looking for U. S. government information and services?
Visit USA. gov
© 2026 Granted AI